产品名称 | NebuSelect™ Recombinant Mouse CD96/TACTILE, His-tag |
---|---|
目录号 | NBL-242847 |
别名 | CD96/TACTILE; CD96 molecule; CD96; DKFZp667E2122; TACTILE |
外观 | see COA |
分子量 | Val22-Met536 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q3U0X8 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242847-100ug | 100ug | Inquire | Inquire | |
NBL-242847-1mg | 1mg | Inquire | Inquire | |
NBL-242847-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse CD96/TACTILE, His-tag
Catalog#:
NBL-242847
Description:
NebuSelect™ Recombinant Mouse CD96/TACTILE, His-tag(Cat#NBL-242847) is expressed in HEK293 with His tag at the C-Terminus.It contains Val22-Met536.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 57.9 kDa. Due to glycosylation, the protein migrates to 90-130 kDa based on Bis-Tris PAGE result.
Target Name:
CD96/TACTILE; CD96 molecule; CD96; DKFZp667E2122; TACTILE
Target Information:
The receptors CD96 and TIGIT are expressed on the surface of T and natural killer (NK) cells, and recent studies suggest both play important inhibitory roles in immune function. CD96 has been shown to modulate immune cell activity in mice, with Cd96-/- mice displaying hypersensitive NK-cell responses to immune challenge and significant tumor resistance. The counterbalance between the putative inhibitory CD96 and TIGIT receptors and the activating receptor, CD226, offers unique strategies for immuno-oncology drug development.
Amino Acid Sequence:
Val22-Met536
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.